FMBTD
BCRX icon

First Midwest Bank Trust Division’s BioCryst Pharmaceuticals BCRX Stock Holding History

First Midwest Bank Trust Division’s Portfolio BCRX Stock Details BCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-412,366
Closed -$1.18M – 358
2019
Q3 		$1.18M Sell
412,366
-60,238
-13% -$187K 0.17% 142
2019
Q2 		$1.79M Buy
+472,604
New +$2.84M 0.26% 104

Other funds holding BCRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

First Midwest Bank Trust Division's BCRX Position: Q4 2019 in Review

First Midwest Bank Trust Division sold out of BioCryst Pharmaceuticals (BCRX) in Q4 2019, closing a stake of 412,366 shares — an estimated $1.18M sold.

First Midwest Bank Trust Division first reported a position in BCRX in Q2 2019 and held it in 2 quarters. The position peaked at $1.79M in Q2 2019. 136 funds tracked by Wall St. Rank hold BCRX as of Q4 2019.

  • First Midwest Bank Trust Division reported no remaining BioCryst Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • First Midwest Bank Trust Division sold 412,366 BioCryst Pharmaceuticals shares in Q4 2019, an estimated $1.18M.
  • First Midwest Bank Trust Division first reported a position in BioCryst Pharmaceuticals in Q2 2019 and held it in 2 quarters.
  • First Midwest Bank Trust Division's BioCryst Pharmaceuticals position peaked at $1.79M in Q2 2019.
  • 136 funds tracked by Wall St. Rank held BioCryst Pharmaceuticals as of Q4 2019.

Based on First Midwest Bank Trust Division's 13F filing for Q4 2019, filed 23 Jan 2020.